# A systematic review and meta-analysis of the efficacy and safety of the interleukin (IL)-12/23 and IL-17 inhibitors ustekinumab, secukinumab, ixekizumab, brodalumab, guselkumab and tildrakizumab for the treatment of moderate to severe plaque psoriasis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/a-systematic-review-and-meta-analysis-of-the-efficacy-and-safety-of-the/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jawad Bilal,Adam Berlinberg,Sandipan Bhattacharjee,Jaren R. Trost,Irbaz Bin Riaz,Drew J.B. Kurtzman |
| Citations | 130 |
| DOI | 10.1080/09546634.2017.1422591 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://figshare.com/articles/journal_contribution/A_systematic_review_and_meta-analysis_of_the_efficacy_and_safety_of_the_interleukin_IL_-12_23_and_IL-17_inhibitors_ustekinumab_secukinumab_ixekizumab_brodalumab_guselkumab_and_tildrakizumab_for_the_treatment_of_moderate_to_severe_plaque_psoriasis/6047894 |
| OpenAlex ID | https://openalex.org/W2792924793 |
| PMID | 29532693 |
| Type | review |
| Year | 2018 |

## Paper authors

- [Sandipan Bhattacharjee](https://scholariq.org/researchers/sandipan-bhattacharjee/)

## Paper primary topic

- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)

## Paper topics

- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.